Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...

Interferonrubbning kan förklara svår covid-19

Genförändringar i interferonsystemet kan vara förklaringen till varför vissa personer får livshotande symtom vid covid-19 medan andra knappt märker av sjukdomen...

A platform for dialogue

As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Vinnova ger stöd till precisionsmedicin – här är projekten som får anslag

Vinnova anslår totalt 323 miljoner kronor i en stor satsning på precisionsmedicin.

Immunicum-teknik i lyckad preklinisk studie

Resultaten publiceras i en vetenskaplig tidskrift.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Tar in 250 miljoner

- Klinisk utveckling i sen fas kostar mycket pengar och därför väljer vi att noteras just nu, säger Peter Zerhouni, vd på Index Pharmaceuticals som genomför en ...

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

Sales Representative, Applied Biosystems

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Grundare och känd forskare lämnar Alligator Bioscience

Alligator Bioscience grundare Carl Borrebaeck lämnar bolaget i protest mot valberedningens förslag på ny styrelse. ”Företaget dräneras på immunonkologisk kompetens”, säger han.

Follicum tar USA-patent

Lundaföretaget Follicums peptider mot diabetes patenteras i USA.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Ny metod förutser lovande läkemedel

Enligt en ny studie kan forskningsbolaget Attanas teknik förbättra lyckandegraden för kliniska studier.

Next generation sequencer in an accessible format

The GS Junior System is a new benchtop-sized next generation sequencing platform.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Avtalet med Almirall sägs upp

Index får tillbaka de europeiska rättigheterna för läkemedelskandidaten Kappaproct mot ulcerös kolit.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Stort intresse för New Horizons

Just nu pågår livesändningen av Life Science Swedens event New Horizons in Biologics & Bioprocessing – och intresset är rekordstort.

Tio minuters trädgårdsarbete räcker

Så lite som tio minuters motion per vecka ser ut att minska risken för hjärtdöd, enligt en kinesisk observationsstudie.